The Programme

September 24-26 2017 — Corinthia Hotel, Prague, Czech Republic

INTRODUCTION

You will have the opportunity to start the conference early on Sunday, September 24 with our educational workshops.

The plenary session on September 25 & 26 will be structured around three main sessions, introduced by our keynote speakers. Additional speakers will be invited based on abstract submissions. The call for abstracts is now open and will close on May 15.

The conference will be followed by the EATRIS Combined Platform Meeting for EATRIS members from September 26 afternoon until lunch time on September 27. For more information on that meeting, please visit our dedicated page.

Please note that the programme below is subject to change.

Sunday, 24 September

Start your conference early with our Sunday workshops

12:30 - 13:30
Registration
13:30 - 19:00
Educational Workshops
Two workshop sessions: 13:30 - 16:00 and 16:30 - 19:00
13:30 - 16:00
Workshop A
A: IN-VITRO DIAGNOSTICS (IVD) DEVELOPMENT
13:30 - 16:00
Workshop B
CHALLENGES AND BEST PRACTICES IN ACADEMIC DRUG DEVELOPMENT
13:30 - 16:00
Workshop C
DESIGNING YOUR RESEARCH FOR MAXIMUM IMPACT: BUILDING A DATA PACKAGE FIT FOR INVESTMENT
16:00 - 16:30
Coffee break
16:30 - 19:00
Workshop D
POTENCY ASSAYS IN ATMP’S AND VACCINES
16:30 - 19:00
Workshop E
MOLECULAR IMAGING SUPPORTING CNS DRUG DEVELOPMENT
16:30 - 19:00
Workshop F
DESIGNING YOUR RESEARCH FOR MAXIMUM IMPACT – HOW TO ASSESS AND MAXIMISE THE POTENTIAL IMPACT OF YOUR RESEARCH PLAN

Monday, 25 September

08:30 - 09:30
Registration / Posters presentation
09:30 - 10:00
Welcome Words
Representatives of Czech Research Ministry (tbd); Marian Hajduch (IMTM, EATRIS Czech Node); Anton Ussi & Giovanni Migliaccio (EATRIS Executive Board)

Plenary session I: The funder, developer and regulator as partners in innovation

10:00 - 10:20
Ruxandra Draghia-Akli, Deputy Director-General for Research and Innovation (tbc)
European Commission
10:20 - 10:40
Isabelle Moulon, Senior Advisor on Stakeholders Engagement
European Medicines Agency
10:40 - 11:00
Clayton Heijman, Director
Privium Fund Management
11:00 - 11:20
Anton Ussi & Giovanni Migliaccio, EATRIS Executive Board
Academia as enablers of innovation
11:30 - 12:00
Coffee break / Posters presentation
12:00 - 13:00
Panel session
Increasing efficiency of the system by bringing funder, researcher and regulator closer together
13:00 - 14:00
Lunch / Posters presentation

Plenary session II: Novel approaches in clinical development

14:00 - 14:25
Philip Murphy, Head Experimental Medicine Imaging
GSK
14:25 - 14:50
Ragnhild Marie Loeberg, Senior Vice President, Quality & Regulatory Affairs
BAYER Algeta
14:50 - 15:15
Mark Schmidt, Senior Director R&D
Janssen
15:15 - 15:40
Marian Hajduch, Director
Institute of Molecular and Translational Medicine
15:40 - 16:10
Coffee break / Posters presentation
16:10 - 18:00
Abstract-based selected speakers
Names will be annouced early June
18:00 - 20:00
Networking cocktail for all conference attendees
Bellevue Hall

Tuesday, September 26

Plenary session III: Developing more predictive preclinical tools to better reach proof of concept

09:00 - 09:10
Summary of discussions Day 1
09:10 - 09:35
Speaker TBA
09:35 - 10:00
Christopher Austin, Director
NIH-NCATS
10:00 - 10:25
Per Avidsson, Executive Director Drug Discovery & Development
SciLifeLab at Karolinska Institutet
10:25 - 11:00
Abstract-based selected speakers
Names will be annouced early June
11:00 - 11:30
Coffee break / Posters presentation
11:30 - 13:00
Abstract-based selected speakers
Names will be annouced early June
13:00
Closing of the conference
13:00 - 14:00
Lunch

Tuesday, September 26

EATRIS Combined Platform Meeting

14:00 - 18:00
EATRIS Combined Platform Meeting (by invitation only – internal meeting)
For more information, please visit: http://eatris.eu/combined-platform-meeting

Wednesday, September 27

09:00 - 14:00
EATRIS Combined Platform Meeting (by invitation only – internal meeting)
For more information, please visit: http://eatris.eu/combined-platform-meeting